Monitoring of the 5-FU therapy: Safety and efficacy of treatment?
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue
Abstract
5-fluorouracil (5-FU) is one of the most common chemotherapeutics used in the therapy of cancers of the gastrointestinal tract, breast, skin or head and neck. The key enzyme of drug metabolism is encoded by DPYD dihydropyrimidine dehydrogenase (DPD), which is responsible for the catabolism of 80% of the administered 5-FU. Patients with DPD deficiency are exposed to a high risk of severe and sometimes lethal toxicity during treatment. Nonlinear pharmacokinetics and narrow therapeutic index significantly hinder the prediction of response of the body after administration of a standard dose. Therefore, the individual adjustment of the optimal dose enabling the best possible therapeutic effect with minimal side effects is very important. The commonly accepted method of adjusting 5-FU dose is based on the body surface area (BSA). Unfortunately, this does not allow us to determine the drug concentration ensuring the highest effectiveness of the treatment while maintaining its safety. Many publications point out the need of determining the activity of dihydropyrimidine dehydrogenase before the administration of 5-FU, which could result in obtaining the desired and optimal drug concentration in the blood, without exposing the patient to its excessive toxicity. Despite the great needs, such tests are not carried out routinely. Specification of procedures of DPD activity indication, determination of optimal 5-FU doses and monitoring of concentration of this chemotherapeutic during the treatment can become the basis for establishing some new therapeutic standards in the oncology, and in consequence, may significantly influence the quality and length of life of the patients.
Authors and Affiliations
Angelika Szczęśniak, Aleksandra Goryniak, Daria Śleboda, Barbara Dołęgowska
Keywords
Related Articles
- EP ID EP270218
- DOI 10.5604/01.3001.0011.5962
- Views 144
- Downloads 0
Diversity of extended-spectrum beta-lactamase-producing Escherichia coli rods
Introduction: The aim of the study was to evaluate genetic relatedness and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing E. coli strains isolated from patients hospitalized in the University...
Hipomelanocytozy dziedziczne: rola genów PAX3, SOX10, MITF, SNAI2, KIT, EDN3 i EDNRB
Jednymi z najcięższych schorzeń dermatologicznych, dotykających pacjentów ze wszystkich regionów świata, są choroby wynikające z hipo- i hiperpigmentacji. Zaburzenia te można podzielić na melanozy, związane z nieprawidło...
Salivary exoglycosidases in the detection of early onset of salivary gland involvement in rheumatoid arthritis
Introduction: The aim of the present study was to evaluate the possibility of making use of the specific activity of N-acetyl-β-hexosaminidase, its isoenzymes and β-glucuronidase – potential indicators of salivary gland...
Infekcje ludzkim wirusem cytomegalii po transplantacji macierzystych komórek krwiotwórczych – metody diagnostyczne i znaczenie monitorowania poziomu DNA wirusa
Zakażenie wirusem hCMV jest powszechne. Nosicielami wirusa jest 30-90% populacji. U osób będących w stanie immunosupresji skuteczna eliminacja wirusa przez komórki efektorowe układu odpornościowego nie jest możliwa. Akty...
Immunoregulacyjne działanie melatoniny. Mechanizm działania i wpływ na komórki procesu zapalnego
Dane literaturowe wskazują na znaczącą rolę melatoniny w regulowaniu układu immunologicznego. Funkcję tę może pełnić bezpośrednio, oddziałując na komórki układu odpornościowego zawierające receptory dla melatoniny, ale r...